GH Research (GHRS) Earnings Date & Reports

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GHRS is expected to report earnings to rise 11.84% to -21 cents per share on August 20

Q2'25

Est.

$-0.21

Q1'25

Beat

by $0.16

Q4'24

Beat

by $0.05

Q3'24

Beat

by $0.01

Q2'24

Beat

by $0.02

The last earnings report on May 08 showed earnings per share of -18 cents, beating the estimate of -34 cents. With 203.75K shares outstanding, the current market capitalization sits at 758.62M.

View a ticker or compare two or three

Compare

GHRS